Aktuellt
SENASTE
Redeye endorses aXichem’s new patent for phenylcapsaicin for use in the treatment of idiopathic pulmonary fibrosis. We are positive about phenylcapsaicin’s potential contribution to the rare disease treatment.
LÄS MER
